Related Experiment Video
Updated: May 23, 2026

Modeling Stroke in Mice: Focal Cortical Lesions by Photothrombosis
Published on: May 6, 2021
Laser-induced thrombus formation in mouse brain microvasculature: effect of clopidogrel
Takuya Fukuoka1, Kimihiko Hattori, Hajime Maruyama
1Department of Neurology, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan. tfukuoka@saitama-med.ac.jp
Abstract:
Antiplatelet drugs have been evaluated by measuring platelet aggregation ex vivo, but in vivo studies were scanty. The purpose of this study was to observe the effects of an antiplatelet agent (clopidogrel) on the process of laser-induced thrombus formation in mice using intravital fluorescence microscopy. C57 BL/6J mice (n = 19) were anesthetized using chloral hydrate. The head of each mouse was fixed with a head holder, and a cranial window was made in the parietal region. Platelets were labeled in vivo by intravenous administration of carboxyfluorescein diacetate succinimidyl ester. Clopidogrel (1 mg/kg, n = 6; 10 mg/kg, n = 6) was administered orally for 2 days before the experiment. Another seven mice were used as controls. Laser irradiation (1,000 mA, 9.8 mW, diode-pumped solid-state (DPSS) laser 532 nm) was directed for 4 s at pial arteries to induce thrombus formation. Labeled platelets and thrombus were observed continuously under fluorescence microscopy. We recorded the area of thrombus after 30 min and determined the complete occlusion rate. After laser irradiation to the pial artery, complete occlusion rate was significantly lower in the clopidogrel (10 mg/kg) group (16%, 4/25 vessels) than in the control group (60%, 12/20 vessels) or clopidogrel (1 mg/kg) group (55%, 11/20 vessels). Area of platelet thrombus at 30 min after laser irradiation was significantly smaller in the clopidogrel (10 mg/kg) group (209 ± 128 μm(2)) than in the control group (358 ± 256 μm(2)) or clopidogrel (1 mg/kg) group (355 ± 57 μm(2)). The apparatus which we developed is convenient for inducing thrombus formation by causing endothelial cell damage to the brain surface vasculature in small animals without damage of extravascular tissue. Clopidogrel significantly inhibited laser-induced thrombus formation in pial arteries of mice in a dose-dependent manner.
Insights
Clopidogrel effectively reduced laser-induced blood clot formation in mouse brain arteries. This study demonstrates clopidogrel
Area of Science:
- * Cardiovascular Research
- * Pharmacology
- * Thrombosis Research
Background:
- * In vivo studies evaluating antiplatelet drugs are limited.
- * Measuring platelet aggregation ex vivo is common, but doesn't fully represent in vivo effects.
- * Understanding in vivo thrombus formation is crucial for antiplatelet drug efficacy.
Purpose of the Study:
- * To investigate the in vivo effects of clopidogrel on laser-induced thrombus formation.
- * To utilize intravital fluorescence microscopy for real-time observation of platelet aggregation.
- * To assess the dose-dependent efficacy of clopidogrel in preventing thrombosis.
Main Methods:
- * C57 BL/6J mice underwent cranial window surgery for pial artery access.
- * Platelets were fluorescently labeled in vivo.
- * Laser irradiation induced thrombus formation in pial arteries.
- * Clopidogrel was administered orally at 1 mg/kg and 10 mg/kg doses prior to laser induction.
Main Results:
- * Clopidogrel (10 mg/kg) significantly reduced the complete occlusion rate (16%) compared to controls (60%).
- * The area of platelet thrombus was significantly smaller in the 10 mg/kg clopidogrel group (209 μm²) versus controls (358 μm²).
- * Inhibition of thrombus formation by clopidogrel was dose-dependent.
Conclusions:
- * Clopidogrel significantly inhibits laser-induced thrombus formation in mouse pial arteries.
- * The developed apparatus allows for convenient in vivo thrombus induction in small animal models.
- * Findings support the in vivo antiplatelet efficacy of clopidogrel.

